Skip to main content
. 2014 Mar 30;2014:621342. doi: 10.1155/2014/621342

Table 5.

Timetable of infections following LTX.

1st month 2nd–6th month >6 months
Nosocomial infections*  
 Respiratory tract infections
 Surgical site infections
 Urinary tract infections
 Catheter infection, sepsis		 Reactivation of latent infections + opportunistic infections Community-acquired infections/pneumonia
Related more to surgery and intensive care Related more to immunosuppression
CF lung pathogens:  
  Pseudomonas spp.
  Burkholderia cepacia complex
  B. gladioli; NTM
  
Other bacteria:  
  S. aureus  
  Enterobacteriaceae  
 Enterococci
  Acinetobacter spp.
  
Fungi:  
  Candida spp.
  (Aspergillus spp.)
  
Viruses:  
 Herpes simplex virus
 Respiratory viruses		 Viruses:  
 Cytomegalovirus
 Epstein-Barr virus
 Herpes simplex virus
 Varicella Zoster virus
  
Opportunists:  
  P. jirovecii  
 Toxoplasmosis
  Aspergillus spp.
 Nocardia
 Listeria
 Mycobacteria
 (especially NTM)
  
CF-lung pathogens:  
  Pseudomonas spp.
  Burkholderia spp.		 Viruses:  
 Epstein-Barr virus
 Respiratory viruses
  
  
Respiratory bacteria:  
  S. pneumonia  
  H.influenzae  
  C. pneumoniae  
  M. pneumoniae  
 and others

CF lung pathogens:  
  Pseudomonas spp.
  Burkholderia spp.
  
Fungi:  
  Aspergillus spp.
C. difficile infection** Late-onset C. difficile infection

*May occur also in later periods after LTX depending on prolonged or recurrent hospitalisation and the presence of medical devices.

**Highest incidence within the first 3 up to 12 months after LTX in association with broad antimicrobial therapy and intense immunosuppression.